Syncom Formulations (India) Limited
SYNCOMF
Rank in Stocks
#16391
Established in 1985 and based in Indore, India, Syncom Formulations (India)... Established in 1985 and based in Indore, India, Syncom Formulations (India) Limited specializes in the development, marketing, and sale of a wide array of finished pharmaceutical products. The company provides an extensive portfolio addressing numerous therapeutic categories, including but not limited to pain relief, infectious diseases, cardiovascular health, mental well-being, respiratory ailments, and nutritional deficiencies, alongside specific treatments for conditions like gout and erectile dysfunction, encompassing both generic and specialized medicines. These medicinal preparations are available in various formats such as tablets, capsules, oral liquids, injectables (both liquid and dry vial), dry syrups, topical ointments, inhalers, and herbal formulations. In addition to its core pharmaceutical business, Syncom Formulations also engages in commodity trading and property leasing. The company serves the domestic Indian market and actively exports its products globally.
Share Price
$0.21574789
Last synced: 2026-11-13
Market Cap
$202.80M
Change (1 day)
-0.13%
Change (1 year)
21.83%
Country
Stock data: Financial Modeling PrepΒ·Updated Β·Not investment adviceΒ·How we calculate this
Trade Syncom Formulations (India) Limited (SYNCOMF)
Category
Healthcare
Earnings for Syncom Formulations (India) Limited (SYNCOMF)
Earnings in Jun 2026 TTM: $12.00M
According to Syncom Formulations (India) Limited's latest financial reports, its current earnings (TTM) are $12.00M. In 2025 the company earned $7.66M, an increase over its 2024 earnings of $4.07M. The earnings shown on this page are earnings before interest and taxes, or EBIT.
Earnings history for Syncom Formulations (India) Limited from 2006 to 2026
Earnings at the end of each year
| Year | Earnings | Change |
|---|---|---|
| 2026 (TTM) | $12.00M | 56.62% |
| 2025 | $7.66M | 88.12% |
| 2024 | $4.07M | 25.93% |
| 2023 | $3.23M | -6.23% |
| 2022 | $3.45M | -37.98% |
| 2021 | $5.56M | 142.29% |
| 2020 | $2.29M | 25.73% |
| 2019 | $1.83M | -1.08% |
| 2018 | $1.85M | -24.63% |
| 2017 | $2.45M | 0.74% |
| 2016 | $2.43M | -3.01% |
| 2015 | $2.51M | 7.84% |
| 2014 | $2.32M | 49.41% |
| 2013 | $1.56M | 44.39% |
| 2012 | $1.08M | 971.10% |
| 2011 | $100.54K | -93.40% |
| 2010 | $1.52M | 39.45% |
| 2009 | $1.09M | -25.10% |
| 2008 | $1.46M | -8.71% |
| 2007 | $1.60M | -0.90% |
| 2006 | $1.61M | 0.00% |
Earnings for similar companies or competitors
| Company | Earnings | Earnings Difference | Country |
|---|---|---|---|
| $3.35B | 27,835.77% |
DE
|
|
| $3.34B | 27,760.25% |
DE
|
|
| $2.50B | 20,778.59% |
JP
|
|
| $930.30M | 7,654.58% |
CH
|
|
| $381.32M | 3,078.48% |
IL
|
Questions about Syncom Formulations (India) Limited's net income
What is Syncom Formulations (India) Limited's net income?
Syncom Formulations (India) Limited's net income over the last twelve months is $12.00M, as of Jun 2026.
What was Syncom Formulations (India) Limited's net income in 2025?
In 2025, Syncom Formulations (India) Limited's net income was $7.66M, 88.12% more than in 2024 ($4.07M).
How has Syncom Formulations (India) Limited's net income changed since 2020?
From 2020 to 2025, Syncom Formulations (India) Limited's net income went from $2.29M to $7.66M, an average growth of 27.26% a year.
How does Syncom Formulations (India) Limited's net income compare with similar companies?
Syncom Formulations (India) Limited's net income ($12.00M) is lower than that of all 5 similar companies listed above. The highest among them is MERCK Kommanditgesellschaft auf Aktien, with $3.35B.